AMGEN INC

0001000 - Document - Cover page

1002000 - Statement - Consolidated Statements of Income

1003000 - Statement - Consolidated Statements of Comprehensive Income

1004000 - Statement - Consolidated Balance Sheets

1004501 - Statement - Consolidated Balance Sheets (Parenthetical)

1005000 - Statement - Consolidated Statements of Stockholders' Equity

1005001 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)

1006000 - Statement - Consolidated Statements of Cash Flows

2101100 - Disclosure - Summary of significant accounting policies

2102100 - Disclosure - Acquisitions

2103100 - Disclosure - Revenues

2104100 - Disclosure - Stock-based compensation

2105100 - Disclosure - Defined contribution plan

2106100 - Disclosure - Income taxes

2107100 - Disclosure - Earnings per share

2108100 - Disclosure - Collaborations

2110100 - Disclosure - Investments

2111100 - Disclosure - Inventories

2113100 - Disclosure - Property, plant and equipment

2114100 - Disclosure - Goodwill and intangible assets

2115100 - Disclosure - Leases

2116100 - Disclosure - Other current assets and accrued liabilities

2117100 - Disclosure - Financing arrangements

2118100 - Disclosure - Stockholders' equity

2119100 - Disclosure - Fair value measurement

2120100 - Disclosure - Derivative instruments

2121100 - Disclosure - Contingencies and commitments

2123100 - Disclosure - Quarterly financial data (unaudited)

2125100 - Disclosure - Subsequent events

2126100 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

2201201 - Disclosure - Summary of significant accounting policies - (Policies)

2302301 - Disclosure - Acquisitions - (Tables)

2303301 - Disclosure - Revenues (Tables)

2304301 - Disclosure - Stock-based compensation (Tables)

2306301 - Disclosure - Income taxes (Tables)

2307301 - Disclosure - Earnings per share (Tables)

2310301 - Disclosure - Investments - (Tables)

2311301 - Disclosure - Inventories (Tables)

2313301 - Disclosure - Property, plant and equipment (Tables)

2314301 - Disclosure - Goodwill and other intangible assets - (Tables)

2315301 - Disclosure - Leases - (Tables)

2316301 - Disclosure - Other current assets and accrued liabilities (Tables)

2317301 - Disclosure - Financing arrangements (Tables)

2318301 - Disclosure - Stockholders' equity (Tables)

2319301 - Disclosure - Fair value measurement - (Tables)

2320301 - Disclosure - Derivative instruments - (Tables)

2321301 - Disclosure - Contingencies and commitments - (Tables)

2323301 - Disclosure - Quarterly financial data (unaudited) (Tables)

2401402 - Disclosure - Summary of significant accounting policies - Narrative (Details)

2402402 - Disclosure - Acquisitions - Narrative (Details)

2402403 - Disclosure - Acquisitions - Otezla (Details)

2402404 - Disclosure - Acquisitions - Aggregate Consideration Paid (Details)

2403402 - Disclosure - Revenues - Narrative (Details)

2403403 - Disclosure - Revenues - Customer Concentration, Product Sales (Details)

2404402 - Disclosure - Stock-based compensation (Textual) (Details)

2404403 - Disclosure - Stock-based compensation (Components of Stock-based Compensation Expense) (Details)

2404404 - Disclosure - Stock-based compensation (Summary of RSUs) (Details)

2404405 - Disclosure - Stock-based compensation Stock-based compensation (Summary of Stock Options) (Details)

2404406 - Disclosure - Stock-based compensation (Summary of Stock Options) (Details)

2404407 - Disclosure - Stock-based compensation (Weighted-average Assumptions) (Details)

2405401 - Disclosure - Defined contribution plan (Details)

2406402 - Disclosure - Income taxes (Income Before Income Taxes) (Details)

2406403 - Disclosure - Income taxes (Provision for Income Taxes) (Details)

2406404 - Disclosure - Income taxes (Components of Deferred Tax Assets and Liabilities) (Details)

2406405 - Disclosure - Income taxes (Textual) (Details)

2406406 - Disclosure - Income taxes (Reconciliation of Total Gross Amounts of UTBs) (Details)

2406407 - Disclosure - Income taxes (Reconciliation of Federal Statutory Tax Rate) (Details)

2407402 - Disclosure - Earnings per share (Details)

2408401 - Disclosure - Collaborations - Novartis AG (Details)

2408402 - Disclosure - Collaborations - Bayer HealthCare Pharmaceuticals Inc. (Details)

2410402 - Disclosure - Investments - Schedule (Details)

2410403 - Disclosure - Investments - Fair Values by Classification (Details)

2410404 - Disclosure - Investments - Available-for-sale (Details)

2410405 - Disclosure - Investments - Fair Values by Contractual Maturity (Details)

2410406 - Disclosure - Investments - Unrealized Losses and Fair Values (Details)

2410407 - Disclosure - Investments - Equity Securities (Details)

2410408 - Disclosure - Investments - Limited Partnership Investments (Details)

2411402 - Disclosure - Inventories (Details)

2413402 - Disclosure - Property, plant and equipment (Schedule) (Details)

2413403 - Disclosure - Property, plant and equipment (Geographic Information) (Details)

2414402 - Disclosure - Goodwill and other intangible assets - Goodwill Roll Forward (Details)

2414403 - Disclosure - Goodwill and other intangible assets - Identifiable Intangible Assets (Details)

2414404 - Disclosure - Goodwill and other intangible assets - Narrative (Details)

2415402 - Disclosure - Leases - Narrative (Details)

2415403 - Disclosure - Leases - Summary of Leases (Details)

2415404 - Disclosure - Leases - Components of Lease Costs (Details)

2415405 - Disclosure - - Maturities of Lease Liabilities (Details)

2415406 - Disclosure - Leases - Cash and Noncash Information of Leases (Details)

2415407 - Disclosure - Leases - Prior to adoption (Details)

2416402 - Disclosure - Other current assets and accrued liabilities Schedule of Other Assets (Details)

2416403 - Disclosure - Schedule of Accrued Liabilities (Details)

2417402 - Disclosure - Financing arrangements (Principal Amounts and Carrying Value of Long-term Borrowings) (Details)

2417403 - Disclosure - Financing arrangements (Debt Issuances) (Details)

2417404 - Disclosure - Financing arrangements (Debt Repayments) (Details)

2417405 - Disclosure - Financing arrangements (Interest Rate and Cross-currency Swaps) (Details)

2417406 - Disclosure - Financing arrangements (Shelf Registration Statements and Other Facilities) (Details)

2417407 - Disclosure - Financing arrangements (Contractual Maturities of Long-term Debt) (Details)

2417408 - Disclosure - Financing arrangements (Interest Costs) (Details)

2418402 - Disclosure - Stockholders' equity (Stock Repurchase Program) (Details)

2418403 - Disclosure - Stockholders' equity (Dividends) (Details)

2418404 - Disclosure - Stockholders' equity (Components of AOCI) (Details)

2418405 - Disclosure - Stockholders' equity (Accumulated Other Comprehensive Income (Loss), Textual) (Details)

2418406 - Disclosure - Stockholders' equity (Reclassifications out of AOCI) (Details)

2418407 - Disclosure - Stockholders' equity (Other) (Details)

2419402 - Disclosure - Fair value measurement - (Fair Value of Financial Assets and Liabilities on Recurring Basis) (Details)

2419403 - Disclosure - Fair value measurement - Narrative (Details)

2420402 - Disclosure - Derivative instruments - Narrative (Details)

2420403 - Disclosure - Derivative instruments - (Cross-currency Swaps) (Details)

2420404 - Disclosure - Derivative instruments - (Effective Portion of Unrealized Gain (Loss)) (Details)

2420405 - Disclosure - Derivative instruments - (Hedged Liabilities and Cumulative Amount) (Details) (Details)

2420406 - Disclosure - Derivative instruments - (Summary of Income and Expense Line Items) (Details)

2420408 - Disclosure - Derivative instruments - (Fair Value of Derivatives) (Details)

2421402 - Disclosure - Contingencies and commitments (Sensipar ANDA Patent Litigation) (Details)

2421403 - Disclosure - Contingencies and commitments (Sandoz Patent Litigation) (Details)

2421404 - Disclosure - Contingencies and commitments (Repatha Patent Litigation) (Details)

2421405 - Disclosure - Contingencies and commitments (NEUPOGEN Patent Litigation) (Details)

2421406 - Disclosure - Contingencies and commitments (EPOGEN Patent Litigation) (Details)

2421407 - Disclosure - Contingencies and commitments (AMJEVITA Patent Litigation) (Details)

2421408 - Disclosure - Contingencies and commitments (KANJINTI Patent Litigation) (Details)

2421409 - Disclosure - Contingencies and commitments (MVASI Patent Litigation) (Details)

2421410 - Disclosure - Contingencies and commitments (Additional Information) (Details)

2421411 - Disclosure - Contingencies and commitments (U.S. Repatriation Tax Commitments) (Details)

2423402 - Disclosure - Quarterly financial data (unaudited) (Details)

2425401 - Disclosure - Subsequent events - Narrative (Details)

2426401 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)